Forestar Group (FOR) Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Forestar Group in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" FOR shares.
View FOR analyst ratings or view top-rated stocks.

3 brokers have issued twelve-month target prices for Forestar Group's shares. Their FOR share price forecasts range from $13.50 to $32.00. On average, they predict the company's stock price to reach $25.83 in the next twelve months. This suggests that the stock has a possible downside of 1.1%.
View analysts price targets for FOR or view top-rated stocks among Wall Street analysts.

Forestar Group's stock was trading at $15.41 at the start of the year. Since then, FOR stock has increased by 69.4% and is now trading at $26.11.
View the best growth stocks for 2023 here.

Forestar Group saw a decline in short interest during the month of September. As of September 15th, there was short interest totaling 395,500 shares, a decline of 13.5% from the August 31st total of 457,400 shares. Based on an average daily volume of 207,300 shares, the days-to-cover ratio is presently 1.9 days. Currently, 2.2% of the company's shares are sold short.
View Forestar Group's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 7th 2023.
View our FOR earnings forecast.

Forestar Group will be holding an earnings conference call on Tuesday, November 7th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 877-481-4010 with passcode "49118".

Forestar Group Inc. (NYSE:FOR) issued its earnings results on Thursday, July, 20th. The oil and gas exploration company reported $0.93 earnings per share for the quarter, beating the consensus estimate of $0.64 by $0.29. The oil and gas exploration company earned $368.90 million during the quarter, compared to analyst estimates of $290.40 million. Forestar Group had a net margin of 11.45% and a trailing twelve-month return on equity of 11.70%.

ETFs with the largest weight of Forestar Group (NYSE:FOR) stock in their portfolio include Amplify Inflation Fighter ETF (IWIN), First Trust Dow Jones Select MicroCap Index Fund (FDM), Hartford Multifactor Small Cap ETF (ROSC) and Royce Quant Small-Cap Quality Value ETF (SQLV).IQ Chaikin U.S. Small Cap ETF (CSML).

4 employees have rated Forestar Group Chief Executive Officer Jim DeCosmo on Glassdoor.com. Jim DeCosmo has an approval rating of 42% among the company's employees. This puts Jim DeCosmo in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Forestar Group investors own include Boeing (BA), Citigroup (C), NVIDIA (NVDA), Toll Brothers (TOL), Enphase Energy (ENPH), Mastercard (MA), Micron Technology (MU), Nokia Oyj (NOK), Pfizer (PFE) and QUALCOMM (QCOM).

Forestar Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "FOR."

Shares of FOR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of FOR stock can currently be purchased for approximately $26.11.

Forestar Group (NYSE:FOR) has a market capitalization of $1.30 billion and generates $1.52 billion in revenue each year. The oil and gas exploration company earns $178.80 million in net income (profit) each year or $2.91 on an earnings per share basis.

The company employs 282 workers across the globe.

Forestar Group's mailing address is 2221 E. LAMAR BLVD. SUITE 790, ARLINGTON TX, 76006. The official website for the company is www.forestar.com. The oil and gas exploration company can be reached via phone at (817) 769-1860, via email at investorrelations@drhorton.com, or via fax at 302-636-5454.